These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 2880719

  • 1. Lack of clinically significant beta-blocking effect of propafenone.
    Cheriex EC, Krijne R, Brugada P, Heymeriks J, Wellens HJ.
    Eur Heart J; 1987 Jan; 8(1):53-6. PubMed ID: 2880719
    [Abstract] [Full Text] [Related]

  • 2. Propafenone shows class Ic and class II antiarrhythmic effects.
    Stoschitzky K, Stoschitzky G, Lercher P, Brussee H, Lamprecht G, Lindner W.
    Europace; 2016 Apr; 18(4):568-71. PubMed ID: 26056191
    [Abstract] [Full Text] [Related]

  • 3. Beta-blocking and electrophysiological effects of propafenone in volunteers.
    Müller-Peltzer H, Greger G, Neugebauer G, Hollmann M.
    Eur J Clin Pharmacol; 1983 Apr; 25(6):831-3. PubMed ID: 6662183
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of oral propafenone in chronic ventricular arrhythmias: a placebo controlled cross-over exercise study.
    Härtel G.
    Eur Heart J; 1985 Feb; 6(2):123-9. PubMed ID: 3891347
    [Abstract] [Full Text] [Related]

  • 5. The efficacy of propafenone on exercise-induced ventricular arrhythmias.
    Cokkinos DV, Perrakis C, Argyrakis S, Hatzisavvas J, Papantonakos A.
    Eur Heart J; 1987 Aug; 8 Suppl D():95-8. PubMed ID: 3678266
    [Abstract] [Full Text] [Related]

  • 6. Different stereoselective effects of (R)- and (S)-propafenone: clinical pharmacologic, electrophysiologic, and radioligand binding studies.
    Stoschitzky K, Klein W, Stark G, Stark U, Zernig G, Graziadei I, Lindner W.
    Clin Pharmacol Ther; 1990 Jun; 47(6):740-6. PubMed ID: 2162749
    [Abstract] [Full Text] [Related]

  • 7. Experimental evidence for beta adrenergic blocking properties of propafenone and for their potential clinical relevance.
    Malfatto G, Pessano P, Zaza A, Schwartz PJ.
    Eur Heart J; 1993 Sep; 14(9):1253-7. PubMed ID: 7901020
    [Abstract] [Full Text] [Related]

  • 8. [Sotalol, propafenone, and flecainide: compared multiparametric analysis of ventricular repolarization in subjects without organic cardiopathy].
    Sarubbi B, Ducceschi V, Briglia N, Esposito R, Mayer MS, Scialdone A, Santangelo L, Iacono A.
    Cardiologia; 1996 Jul; 41(7):645-51. PubMed ID: 8983831
    [Abstract] [Full Text] [Related]

  • 9. The differentiation of propafenone from other class Ic agents, focusing on the effect on ventricular response rate attributable to its beta-blocking action.
    Faber TS, Camm AJ.
    Eur J Clin Pharmacol; 1996 Jul; 51(3-4):199-208. PubMed ID: 9010685
    [Abstract] [Full Text] [Related]

  • 10. Beta-blocking effect of propafenone based on spectral analysis of heart rate variability.
    Lombardi F, Torzillo D, Sandrone G, Dalla Vecchia L, Finocchiaro ML, Bernasconi R, Cappiello E.
    Am J Cardiol; 1992 Oct 15; 70(11):1028-34. PubMed ID: 1357951
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Utility of Routine Exercise Testing to Detect Rate-Related QRS Widening in Patients Without Structural Heart Disease on Class Ic Antiarrhythmic Agents (Flecainide and Propafenone).
    Vallurupalli S, Pothineni NV, Deshmukh A, Paydak H.
    Am J Cardiol; 2015 Sep 01; 116(5):730-2. PubMed ID: 26100588
    [Abstract] [Full Text] [Related]

  • 13. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
    Coumel P, Leclercq JF, Assayag P, Maisonblanche P, Cauchemez B.
    Arch Mal Coeur Vaiss; 1984 Nov 01; 77(12):1370-82. PubMed ID: 6439161
    [Abstract] [Full Text] [Related]

  • 14. Propafenone versus disopyramide: a double-blind randomized crossover trial in patients presenting chronic ventricular arrhythmias.
    Libersa C, Caron J, Pladys A, Beuscart R, Kacet S, Wajman A, Connell C, Dupuis B, Lekieffre J.
    Clin Cardiol; 1987 Jul 01; 10(7):405-10. PubMed ID: 2440632
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. An enantiomer-enantiomer interaction of (S)- and (R)-propafenone modifies the effect of racemic drug therapy.
    Kroemer HK, Fromm MF, Bühl K, Terefe H, Blaschke G, Eichelbaum M.
    Circulation; 1994 May 01; 89(5):2396-400. PubMed ID: 7910120
    [Abstract] [Full Text] [Related]

  • 17. [Effect of propafenone hydrochloride on atrial signal-averaged ECG in patients with paroxysmal atrial fibrillation].
    Telichowski A, Banasiak W, Ponikowski P, Wiech K, Zebrowski J, Pieróg M, Kałka D, Lacheta W, Fuglewicz A, Molenda W.
    Pol Arch Med Wewn; 1995 Aug 01; 94(2):132-43. PubMed ID: 8596748
    [Abstract] [Full Text] [Related]

  • 18. The role of genetically determined polymorphic drug metabolism in the beta-blockade produced by propafenone.
    Lee JT, Kroemer HK, Silberstein DJ, Funck-Brentano C, Lineberry MD, Wood AJ, Roden DM, Woosley RL.
    N Engl J Med; 1990 Jun 21; 322(25):1764-8. PubMed ID: 1971708
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.